MLchartDataset catalogue

Valstar

Term · Oncology and biomedicine · MLC-T-ONC-009157

A drug used to treat bladder carcinoma in situ that did not get better after treatment with bacillus Calmette-Guerin (BCG). It is used in patients who cannot have surgery right away to remove all or part of the bladder. Valstar is given as a solution through a catheter that is placed into the bladder. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Valstar is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Also called AD 32 and valrubicin.

Table 1. Record
IdentifierMLC-T-ONC-009157
FieldOncology and biomedicine
SynonymsAD 32; valrubicin
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009157",
  "term": "Valstar",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat bladder carcinoma in situ that did not get better after treatment with bacillus Calmette-Guerin (BCG). It is used in patients who cannot have surgery right away to remove all or part of the bladder. Valstar is given as a solution through a catheter that is placed into the bladder. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Valstar is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Also called AD 32 and valrubicin.",
  "synonyms": [
    "AD 32",
    "valrubicin"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/valstar/"
}

Record 17,097 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.